Biologics are therapeutic entities composed of sugars, proteins, or nucleic acids made from natural sources such as human, animal or micro organisms. Like small molecule drugs, these drugs are intended for treatment of diseases and medical conditions. Although biologics are much costlier than small molecule drugs, these classes of drugs prove to be highly beneficial for the patient.

1. IQ4I Research & Consultancy Pvt. Ltd. Page 1
Biologics Outsourcing Global Market
–Forecast to 2025
Biologics Outsourcing Global Market estimated to be worth $70.3 billion by
2025
IQ4I Research & Consultancy published a new report on “Biologics Outsourcing
Global Market – Forecast To 2025” This report analyzes and studies the overall market,
major Drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific
and Rest of the World
“BIOLOGICS OUTSOURCING GLOBAL MARKET” report gives comprehensive
insights on the biologics outsourcing global market. The report covers all segments,
global trends and emerging strategies of the outsourcing market related to drug
discovery, preclinical development, clinical phases and commercial manufacturing of
biologics. Major Biologics outsourcing market players included in the report are
Lonza, Genscript, Charles River Laboratories (CRL), Wuxi AppTec, CMC biologics,
Boehringer Ingelheim, Patheon, Catalent, Labcorp (Covance), and Fujifilm diosynth
biotechnologies.
This report caters the need of CROs/CDMOs/CMOs, Pharmaceutical /Biotech companies,
Academic institutes, Individual researchers, Investors, Service providers and other
associated stake holders to identify and analyze the potential of the biologics outsourcing
global market. The report also provide insights on customer base, number of deals between
CRO’s and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of
companies, revenue/employee of major players, therapeutic area gap analysis and
Successful research collaboration outcomes of selected CROs/CDMOs/CMOs and
Sponsors, which are likely to have an impact on the biologics outsourcing global market in
the foreseeable future.
This report covers in-depth analysis of major players by therapeutic area of focus,
capabilities, geographic presence, financials, collaborations, acquisitions, .

2. IQ4I Research & Consultancy Pvt. Ltd. Page 2
Biologics Outsourcing Global Market
–Forecast to 2025
Some of the key sections covered in the report are given below:
The biologics outsourcing global market is estimated region wise with various drug
discovery, development and manufacturing segments and their market shares. This section
also included the market sizing of antibodies, recombinant proteins, vaccines, and others
which included gene therapy, cell therapy. The emerging trends and strategies adopted by
global biopharmaceutical companies and their impact on outsourcing market were
discussed. A list of approved drugs (2012-2016) along with phase wise pipeline analysis for
biologics was included.
• In depth assessment of all segments and sub segments of Biologics Outsourcing global
market
• Regional analysis of biologics outsourcing global market
• Market sizing based on type of Biologics, Therapeutic areas and end users
• Emerging trends and strategies
• A list of approved drugs (2012-2016) along with phase wise and modality based pipeline
analysis for biologics
• Market share analysis of major players in biologics outsourcing global market.
• Biologics services cost analysis for various modalities
• Service provider matrix based on service offerings, revenues and employee size